MENU
ELEV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Elevation Oncology (ELEV) Ownership - Who owns Elevation Oncology?
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs... Show more
Profile
Industry
N/A
Address
101 Federal Street
Phone
+1 716 371-1125
Employees
29
Web
https://www.elevationoncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
21.63M
P/E Ratio
N/A
Total Cash
80.66M
Projected Growth
N/A
Total Debt
31.25M
Revenue
N/A
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash/Share
1.36
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ELEV
Capitalization
21.6M
P/E Ratio
N/A
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash
80.7M
Total Cash/Share
1.36
Total Debt
31.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
46.7M
P/B Ratio
0.46
Cash Flow
N/A
Earnings
-0.81
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
19.40
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-41.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-50.20
Shares Held By Institutions
9.43M
Shares Outstanding - Current
59.3M
Total Liabilities
35.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-35.123
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ELEV showed earnings on May 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
101 Federal Street
Phone
+1 716 371-1125
Employees
29
Web
https://www.elevationoncology.com